We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Driving Speed, Sensitivity and Precision in Modern Proteomics
Industry Insight

Technology Networks spoke with Rohan Thakur, Executive Vice President of Life Sciences Mass Spectrometry at Bruker Daltonics, to discuss the company's latest analytical technologies and their capabilities.

Read More

Asset Monitoring in the Life Sciences: Do Labs Need To Keep a Closer Eye on Their Instruments?
Industry Insight

In the day-to-day of research science, the acquisition of a new piece of equipment is a momentous occasion, but one that could see costs and inefficiencies spiral unless labs keep a close eye on their new kit. Asset monitoring software could lend a hand. We spoke to Agilent's Marc Boreham to find out more.

Read More

Pathology Post COVID-19
Industry Insight

To learn more about the impact the COVID-19 pandemic is having on pathology, what the future of pathology might look like, and how digital pathology could help to ease some of the challenges, we spoke to Mark Lloyd, Founder and Executive Vice President of Inspirata.

Read More

Taking a Closer Look at Trends in Microscopy
Industry Insight

With advances in cellular and tissue-based imaging, researchers are able to peel back the layers on new challenges and test hypotheses to solve more problems. We heard about some of the advancements being made in the field of confocal microscopy.

Read More

Telehealth’s Time Is Now. Can It Take a Leading Role?
Industry Insight

Telehealth is booming. An industry which has long shown its value in long-distance and rural healthcare settings has been moved center stage by the COVID-19 pandemic. We spoke to Daniel Carlin, CEO of provider WorldClinic to discuss the need for care consistency in telehealth, the impact of COVID-19 and whether bespoke telehealth services can become truly mainstream.

Read More

How Automation Can Give Bioengineering a Boost
Industry Insight

Genetic technologies have advanced to the point that digital and experimental approaches can work hand-in-hand. We spoke to Emilie Fritsch, a field application scientist at Synthace, to find out more.

Read More

Tracking Global COVID-19 Clinical Trials
Industry Insight

In efforts to find efficacious interventions against SARS-CoV-2, the novel coronavirus that causes COVID-19, hundreds of clinical trials have been designed and launched at an unprecedented rate across the globe. As data emerges from these studies there is an urgent need to track progress, to ensure transparent communication of findings, and to avoid duplication of efforts. Technology Networks spoke with Cytel’s Edward Mills, Vice President of Real-World Evidence and Senior Principal Scientist, to learn more about the global COVID-19 Trial Tracker the company has recently launched.

Read More

Want To Volunteer for a COVID-19 Trial? This Tool Can Help Connect You
Industry Insight

To try and make the process of applying for COVID-19 clinical trials easier, a free public health initiative called World Without COVID has been launched that will link users with all the trials they are eligible for.

Read More

Startup Collaborates With the Francis Crick Institute To Model COVID-19's Spread Between (and Within) People
Industry Insight

London-based engineering startup Hadean, in collaboration with researchers at the Francis Crick Institute, hopes to use its simulation solution, the Aether Engine, to better model the spread of COVID-19 both between and within people. We spoke to Hadean’s Vice President of Operations, Mimi Keshani, to find out more.

Read More

Developing the World's First Single Molecule Protein Sequencer
Industry Insight

Jagannath Swaminathan is the co-founder of Erisyon and a researcher at the Marcotte Lab at the University of Texas Austin. In this interview, we discuss the concept of next-generation protein sequencing, clinical proteomics and the critical role of protein sequencing in the fight against COVID-19.

Read More

 
Advertisement